secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celularity Inc (CELU)
CIK:        0001752828
Form:       8-K
Filed at:   2021-09-15T23:59:59+00:00
Accession:  0001213900-21-048256
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Celularity appoints Andrew Pecora as President; Hariri remains CEO and Chairman
-------------------------------------------------------------------------------

- Andrew Pecora named President effective Sept 15, 2021, replacing Robert Hariri who stays CEO/Chairman.
- Pecora receives $900K base salary, 60% target bonus, and a signing bonus of $1.2M paid in four installments.
- Granted option to purchase 2,469,282 shares, vesting upon achievement of share price targets over up to five installments.
- Pecora previously served as consultant and on Sci Advisory Board; related party transactions with COTA and son's employment disclosed.
- Employment at-will; severance includes nine months' salary (or 12 months after change in control) and COBRA coverage.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1752828/000121390021048256/0001213900-21-048256-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1752828/000121390021048256/ea147489-8k_celularity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-048256

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer